1[1]Santomauro AT, Bodern G, Silva ME, et al. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diiabetes, 1999,48:1836
2[2]Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes, 1997,46: 3
3[3]Shimabukuro M, Zhou YT, Levi M, Unger RH. Fatty acid-induced cell apoptosis:A link between obesity and diabetes. Proc Natl Acad Sci, 1998,95: 2498
4[4]Bliiher M, Kratzsch J, Paschke R. Serum levels of tumor necrosis factor-α, angiotensin II , growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance. Diabetes Care, 2001,24: 328
5[5]Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metabolism Re- viects, 1998,14:263
6[6]Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: Genetic and clinical implications. Diabetes, 1995,44: 863